Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents - Wikidata - awgldk - TriplyDB

Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents

Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents

http://www.wikidata.org/entity/Q33829659

about

A Raman-based endoscopic strategy for multiplexed molecular imaging.Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review Meloxicam prevents COX-2-mediated post-surgical inflammation but not pain following laparotomy in mice (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2 Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy Bifunctional Conjugates with Potent Inhibitory Activity Towards Cyclooxygenase and Histone Deacetylase Seeing it through: translational validation of new medical imaging modalities.Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer Trifluoromethyl fluorocoxib a detects cyclooxygenase-2 expression in inflammatory tissues and human tumor xenografts In situ click chemistry generation of cyclooxygenase-2 inhibitors.Utility of a human-mouse xenograft model and in vivo near-infrared fluorescent imaging for studying wound healing Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines.Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance.Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 Inhibitors.Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.A cyclooxygenase-2-dependent prostaglandin E2 biosynthetic system in the Golgi apparatus Detection of non-melanoma skin cancer by in vivo fluorescence imaging with fluorocoxib A.Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer.Targeted imaging of cancer by fluorocoxib C, a near-infrared cyclooxygenase-2 probe Transforming growth factor beta signaling in adult cardiovascular diseases and repair.A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application Inflammation and cancer: chemical approaches to mechanisms, imaging, and treatment.Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitors Fluorocoxib A enables targeted detection of cyclooxygenase-2 in laser-induced choroidal neovascularization.Towards aspirin-inspired self-immolating molecules which target the cyclooxygenases.Transgenic mouse model for imaging of interleukin-1β-related inflammation in vivo.Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine model Design, synthesis, and structure-activity relationship studies of fluorescent inhibitors of cycloxygenase-2 as targeted optical imaging agents The 2'-Trifluoromethyl Analogue of Indomethacin Is a Potent and Selective COX-2 Inhibitor Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.Gelatin-based Hydrogel Degradation and Tissue Interaction in vivo: Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice.2-Carbaborane-3-phenyl-1H-indoles--synthesis via McMurry reaction and cyclooxygenase (COX) inhibition activity.Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.Exploiting the tumor microenvironment for theranostic imaging.Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity--a critical update.Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation.Radioiodinated indomethacin amide for molecular imaging of cyclooxygenase-2 expressing tumors.

P2860

Q24609293-FAAB32C6-0A7E-4D2F-AA40-EC903E655AE1 Q26750933-9041B61C-AD75-4226-821B-17EFC17D2463 Q27335431-2062351C-7D70-4AAB-899C-519EB5A2F4A4 Q27675386-D97E9C81-8CC3-4DC4-A045-21E5DA637701 Q28076041-99A68C8E-0DC0-47DF-8D1F-41217C03DFF1 Q28383826-8856D736-DB2A-4AC5-A063-0490EDCD0A92 Q29248227-AE1EF418-6C06-4913-9995-66260CA01CDC Q30467703-F7BFFD1C-0A88-46A8-83F4-79D60430647E Q30743369-30652658-95EB-47C6-B5EB-581905FDD141 Q33636439-FD5F1B96-692F-40E2-8A53-6261DEB494F1 Q33687262-2DB0EF6F-A1A8-4EBB-8968-5B8D4AB58455 Q33794168-D7E90DC6-4ECB-4AC1-B54B-07D30D843CD6 Q33849066-801F2757-1527-4B1D-B090-E8D17625A209 Q34060461-4011F933-C2C7-439C-BEFE-76086F11AA5B Q34519695-4108E158-A221-430D-9D23-957F05D9134C Q34785236-CEF26E76-26AF-490D-980D-B7E07CC3856B Q35126657-69819A0C-D8E6-47BD-83C4-C1131CB23A8B Q35152553-F25FC557-F175-4769-8824-9C07B1C58753 Q35334366-1301D756-9E07-4843-B1B0-1549409212CB Q35545603-54B3832A-11E8-4F71-AC91-104BC5A39E6D Q35602497-DBA273AC-3F5C-418C-B6B8-8DBCA1258CCB Q35895390-EB278280-DFC5-408D-9F7F-1A12E21176F0 Q35942615-FA1E8B39-0CDA-4401-8E37-D659BE1101F8 Q36033937-B217DFD1-5570-4B79-B4A1-1B53A88959E4 Q36121287-9918D614-DABD-4B28-9FF6-BAA294557394 Q36132441-C67D40E4-6F85-463E-9513-115099A8C8E6 Q36277653-0FD738DF-BD8B-432E-882A-F41FFBAA14FA Q36310226-CDC40339-8318-418E-9BFE-32155148D533 Q36356814-97CD7429-A7FD-4BEC-864E-0126172B0DF9 Q36779116-CDEF894E-15CD-4FE2-9B79-2D847E152025 Q36845761-07AA5DE6-4254-49A3-AC4E-2A9DC2C65CF3 Q36900405-A1AD2FB4-41A1-4FDA-8F05-FA937795651C Q37213786-D6D5F114-BD07-40D3-9E7A-3546FB7CEAB5 Q37291281-C35A705E-6F78-4B14-BE79-BBB7DD032DCD Q37361431-6D594D16-FFAD-42C8-AC69-D6EE8932BE2C Q37687521-3653DF77-70E8-4303-95D4-0C04E2D6B654 Q37906480-E865BE69-2F9D-461F-9E34-CF2A07C12715 Q38113933-3215607E-8FCB-4B6A-BB1E-BE905FC072FB Q38759610-BAD639CE-6131-4ACD-96BC-D9F419453310 Q38837961-CC502F2E-C617-4B90-993A-68C92C6927AA

P2860

Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents

http://www.wikidata.org/entity/Q33829659

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Selective visualization of cyc ...... ted fluorescent imaging agents

@ast

Selective visualization of cyc ...... ted fluorescent imaging agents

@en

type

label

Selective visualization of cyc ...... ted fluorescent imaging agents

@ast

Selective visualization of cyc ...... ted fluorescent imaging agents

@en

prefLabel

Selective visualization of cyc ...... ted fluorescent imaging agents

@ast

Selective visualization of cyc ...... ted fluorescent imaging agents

@en

P1433

Q33829659-A6207DED-4272-4CDF-92C7-D1A9CCDE00BB

P1476

Q33829659-519C1022-A8F5-4DEA-BC51-EAB6A0E49CC7

P2093

Q33829659-0A3C0311-E04B-4EAF-B72D-02C7C2B47566

Q33829659-25E7693C-2C56-496B-A881-E6FE29DE3C4C

Q33829659-2BFE8316-BCAE-4981-956F-28B2B93A347C

Q33829659-3851E532-7897-4E4E-8908-2059B0C7E1F6

Q33829659-42ABC094-C671-4430-81B6-295EA66055A2

Q33829659-6ECA9FC9-8B78-43DE-855B-2321031E4D44

Q33829659-9ECE298C-B56B-473C-B2D4-D4E653D73745

Q33829659-BB3380D2-470A-4F0F-9102-92CAA8367848

Q33829659-C82E6986-890B-41D8-B926-8A5ED90D1541

Q33829659-F9366E63-D0AF-48CB-8BEF-3A4025336A4B

P2860

Q33829659-020E760F-05F0-4B25-8447-275BCBC6E087

Q33829659-1AD90908-5AEE-4ED8-813F-309D860F800F

Q33829659-1D08EA7A-9648-432A-A01A-E4AAC70F7872

Q33829659-20A1E878-774A-476E-A25B-30922F1C7912

Q33829659-212603E3-2C77-4EA1-B52F-194BAD49947F

Q33829659-2B9EBE89-2BFF-4ECA-909E-05C8880A7D50

Q33829659-3534DCD3-7E6E-4F1B-A064-9D67567DC97C

Q33829659-39BDCB13-C815-4E06-866F-CAC31DD67589

Q33829659-3F7A9F5D-EA3E-4EB4-982F-E599EB0FCBEC

Q33829659-43339CCF-D77F-4A8D-A51A-7FF4EF2C0053

P304

Q33829659-E20E4492-A528-469A-B180-8A3F55F3CA14

P31

Q33829659-021D233D-B2A2-4DBE-B152-212438F7C309

P356

Q33829659-53F795A7-AB12-4B4A-9A62-CF16D4AFEDEE

P407

Q33829659-B291A9AB-53AF-4299-AFEB-41CE854036FB

P433

Q33829659-2F5E03AF-0723-43C3-8AD1-EE91769BA6D5

P478

Q33829659-70294CC1-8620-4454-A78C-A3B40CC3BB83

P577

Q33829659-9CA263CE-6B52-49CE-842C-993340F73BC0

P698

Q33829659-1601E6BD-96E4-4AC5-A156-7CC9A544D275

P921

Q33829659-5D7759D0-CE74-40E3-9182-E513880CE831

P932

Q33829659-0DF414E8-7F2C-4DCA-8D15-F3B49D868027

P356

0008-5472.CAN-09-2664

P1433

Cancer Research

P1476

Selective visualization of cyc ...... ted fluorescent imaging agents

@en

P2093

Andrew J Dannenberg

http://www.w3.org/2001/XMLSchema#string

Anna L Blobaum

http://www.w3.org/2001/XMLSchema#string

Brenda C Crews

http://www.w3.org/2001/XMLSchema#string

D Lee Gorden

http://www.w3.org/2001/XMLSchema#string

David W Piston

http://www.w3.org/2001/XMLSchema#string

J Oliver McIntyre

http://www.w3.org/2001/XMLSchema#string

Kotha Subbaramaiah

http://www.w3.org/2001/XMLSchema#string

Lawrence J Marnett

http://www.w3.org/2001/XMLSchema#string

Lynn M Matrisian

http://www.w3.org/2001/XMLSchema#string

Md Jashim Uddin

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

Cyclooxygenase enzymes: catalysis and inhibition

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

COX-1 and COX-2 tissue expression: implications and predictions.

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.

P304

3618-3627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-2664

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20430759

http://www.w3.org/2001/XMLSchema#string

P921

P932

2864539

http://www.w3.org/2001/XMLSchema#string